|
Volumn 44, Issue 10, 2000, Pages 2816-2823
|
Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2' DEOXY 3' OXATHIOCYTIDINE;
PLACEBO;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG URINE LEVEL;
ENANTIOMER;
HUMAN;
HUMAN EXPERIMENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
ADOLESCENT;
ADULT;
AREA UNDER CURVE;
CROSS-OVER STUDIES;
DEOXYCYTIDINE;
HUMANS;
MALE;
MIDDLE AGED;
REVERSE TRANSCRIPTASE INHIBITORS;
SINGLE-BLIND METHOD;
SPECTROPHOTOMETRY, ULTRAVIOLET;
STEREOISOMERISM;
THIONUCLEOSIDES;
|
EID: 0033802584
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.44.10.2816-2823.2000 Document Type: Article |
Times cited : (3)
|
References (11)
|